FDA May Seek Industry's Blanket Consent For Trade Secret Info Release
This article was originally published in The Tan Sheet
Executive Summary
FDA is seeking alternatives to the current practice of obtaining industry consent on a case-by-case basis to share confidential commercial information and trade secrets with foreign governments, FDA Associate Director for International Agreements Merton Smith said at a Dec. 8 public meeting.
You may also be interested in...
Block Drug Labeling Exemption Request For BC Analgesic Powder Denied
Block Drug's request for an exemption from the OTC labeling final rule for its BC analgesic powder was denied by FDA Aug. 28.
Block Drug Labeling Exemption Request For BC Analgesic Powder Denied
Block Drug's request for an exemption from the OTC labeling final rule for its BC analgesic powder was denied by FDA Aug. 28.
Block Drug Labeling Exemption Request For BC Analgesic Powder Denied
Block Drug's request for an exemption from the OTC labeling final rule for its BC analgesic powder was denied by FDA Aug. 28.